Apricus Biosciences (NASDAQ:APRI) has closed its public offering of ~7.1M shares of common stock at $0.50 per share. Investors also received five-year warrants to purchase up to ~3.55M shares at $0.50 per share.
Gross proceeds were ~$3.55M. Net proceeds will fund working capital and general corporate purposes.
Subscribe for full text news in your inbox